www.stirlingproducts.net
Stirling Products (ASX:STI) is a manufacturer and marketer of proprietary and/or patented pharmaceutical products and natural health products for its own interests as well as on a contractual basis for third parties. Strategically, Stirling Products is positioned to capitalise on the rapidly changing conditions within the global pharmaceutical and health markets.
The Stirling Products corporate headquarters are in Sydney, Australia and its North American pharmaceutical manufacturing operations are based on Cape Breton, Nova Scotia, Canada.
Stirling operates through three main business units each managed by proven industry specialist managers:
- Pharmaceutical & Healthcare
- Research & Development
- Animal Products
Stirling Products in talks to appoint CEO, seeks London AIM listing
Stirling Products (ASX: STI) has not proceeded with formalising the appointment of Jeremy Cocks as CEO following last month's announcement of his conditional appointment.
The company said it is in discussion with other parties with regard to this position and will advise the market accordingly.
Stirling Products has also announced that it has begun the process of seeking a dual listing on the London Stock Exchange Alternative Investment Market (AIM).
This is being done so that the company can benefit from the increased UK and European investment industry exposure of the pharmaceutical and healthcare industry.
The company is continuing with a review of its operations and has placed its properties in O’Connell Street, Sydney, on the market.


















